Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Diabetologia
|
February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation
A C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2002
Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2
A C Calkin, K Sudhir, S Honisett, et al.
Current Pharmaceutical Design
|
September 28, 2007
PPARs and diabetes-associated atherosclerosis
A C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
G Soldatos, K Jandeleit-Dahm, H Thomson, et al.
Diabetologia
|
October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis
Y Pham, Y Tu, T Wu, et al.
Diabetologia
|
January 25, 2013
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
A M D Watson, M Olukman, C Koulis, et al.
Diabetologia
|
December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
A M D Watson, A Soro-Paavonen, K Sheehy, et al.
Iscience
|
January 31, 2024
Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's disease
J P S Marshall, K Huynh, G I Lancaster, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Diabetologia
|
February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation
A C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2002
Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2
A C Calkin, K Sudhir, S Honisett, et al.
Current Pharmaceutical Design
|
September 28, 2007
PPARs and diabetes-associated atherosclerosis
A C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
G Soldatos, K Jandeleit-Dahm, H Thomson, et al.
Diabetologia
|
October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis
Y Pham, Y Tu, T Wu, et al.
Diabetologia
|
January 25, 2013
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
A M D Watson, M Olukman, C Koulis, et al.
Diabetologia
|
December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
A M D Watson, A Soro-Paavonen, K Sheehy, et al.
Iscience
|
January 31, 2024
Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's disease
J P S Marshall, K Huynh, G I Lancaster, et al.
Page
of 1